Patani Neill, Jiang Wen, Newbold Robert, Mokbel Kefah
Department of Breast Surgery, The London Breast Institute, The Princess Grace Hospital, London.
J Carcinog. 2010 Nov 12;9:9. doi: 10.4103/1477-3163.72505.
Ubiquitin modification of proteins influences cellular processes relevant to carcinogenesis. CHIP (carboxyl-terminus of Hsc70-interacting protein) is a chaperone-dependent E3 ubiquitin ligase, regulating the stability of heat shock protein 90 (HSP90) interacting proteins. CHIP is implicated in the modulation of estrogen receptor (ESR1) and Her-2/neu (ERBB2) stability. LOX (lysyl-oxidase) serves intracellular roles and catalyses the cross-linking of extracellular matrix (ECM) collagens and elastin. LOX expression is altered in human malignancies and their peri-tumoral stroma. However, paradoxical roles are reported. In this study, the level of mRNA expression of CHIP and LOX were assessed in normal and malignant breast tissue and correlated with clinico-pathological parameters.
Breast cancer (BC) tissues (n = 127) and normal tissues (n = 33) underwent RNA extraction and reverse transcription; transcript levels were determined using real-time quantitative PCR and normalized against CK-19. Transcript levels were analyzed against TNM stage, nodal involvement, tumor grade and clinical outcome over a ten-year follow-up period.
CHIP EXPRESSION DECREASED WITH INCREASING NOTTINGHAM PROGNOSTIC INDEX (NPI): NPI-1 vs. NPI-3 (12.2 vs. 0.2, P = 0.0264), NPI-2 vs. NPI-3 (3 vs. 0.2, P = 0.0275). CHIP expression decreased with increasing TNM stage: TNM-1 vs. TNM-2 (12 vs. 0, P = 0.0639), TNM-1 vs. TNM-2-4 (12 vs. 0, P = 0.0434). Lower transcript levels were associated with increasing tumor grade: grade 1 vs. grade 3 (17.7 vs. 0.3, P = 0.0266), grade 2 vs. grade 3 (5 vs. 0.3, P = 0.0454). The overall survival (OS) for tumors classified as 'low-level expression', was poorer than those with 'high-level expression' (118.1 vs. 152.3 months, P = 0.039). LOX expression decreased with increasing NPI: NPI-1 vs. NPI-2 (3 vs. 0, P = 0.0301) and TNM stage: TNM-1 = 3854639, TNM-2 = 908900, TNM-3 = 329, TNM-4 = 1.232 (P = NS).
CHIP expression is associated with favorable prognostic parameters, including tumor grade, TNM stage and NPI. CHIP expression predicts OS. LOX expression is associated with improved NPI. In addition to their prognostic utility, mechanistic insights into tumor suppressor function may offer potential therapeutic strategies.
蛋白质的泛素修饰影响与致癌作用相关的细胞过程。CHIP(Hsc70相互作用蛋白的羧基末端)是一种伴侣依赖性E3泛素连接酶,调节热休克蛋白90(HSP90)相互作用蛋白的稳定性。CHIP与雌激素受体(ESR1)和Her-2/neu(ERBB2)稳定性的调节有关。赖氨酰氧化酶(LOX)在细胞内发挥作用,并催化细胞外基质(ECM)胶原蛋白和弹性蛋白的交联。LOX表达在人类恶性肿瘤及其肿瘤周围基质中发生改变。然而,也有矛盾的作用报道。在本研究中,评估了CHIP和LOX在正常和恶性乳腺组织中的mRNA表达水平,并与临床病理参数相关联。
乳腺癌(BC)组织(n = 127)和正常组织(n = 33)进行RNA提取和逆转录;使用实时定量PCR测定转录水平,并以CK-19进行标准化。在十年随访期内,针对TNM分期、淋巴结受累情况、肿瘤分级和临床结局分析转录水平。
CHIP表达随诺丁汉预后指数(NPI)增加而降低:NPI-1与NPI-3相比(12.2对0.2,P = 0.0264),NPI-2与NPI-3相比(3对0.2,P = 0.0275)。CHIP表达随TNM分期增加而降低:TNM-1与TNM-2相比(12对0,P = 0.0639),TNM-1与TNM-2-4相比(12对0,P = 0.0434)。较低的转录水平与肿瘤分级增加相关:1级与3级相比(17.7对0.3,P = 0.0266),2级与3级相比(5对0.3,P = 0.0454)。分类为“低水平表达”的肿瘤的总生存期(OS)比“高水平表达”的肿瘤差(118.1对152.3个月,P = 0.039)。LOX表达随NPI增加而降低:NPI-1与NPI-2相比(3对0,P = 0.0301)以及随TNM分期降低:TNM-1 = 3854639,TNM-2 = 908900,TNM-3 = 329,TNM-4 = 1.232(P = 无显著性差异)。
CHIP表达与良好的预后参数相关,包括肿瘤分级、TNM分期和NPI。CHIP表达可预测OS。LOX表达与改善的NPI相关。除了它们的预后效用外,对肿瘤抑制功能的机制性见解可能提供潜在的治疗策略。